Health CareHealth Care Equipment & Services
  • Price (EUR)178.18
  • Today's Change-3.46 / -1.90%
  • Shares traded277.81k
  • 1 Year change+41.36%
  • Beta0.8386
Data delayed at least 15 minutes, as of Dec 02 2021 14:50 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

EssilorLuxottica SA, formerly known as Essilor International Compagnie Generale D Optique SA, is a France-based ophthalmic company. The Company designs, manufactures and markets a range of lenses, frames and sunglasses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. The Company operates under a number of brands, including Ray-Ban, Oakley and Varilux, among others. The Company operates in Europe, North America, Asia Pacific, the Middle East, Africa and Latin America.

  • Revenue in EUR (TTM)16.97bn
  • Net income in EUR1.35bn
  • Incorporated1993
  • Employees144.51k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EL:PAR since
Lenstec Optical Group LtdAnnounced27 Apr 202127 Apr 2021Announced26.96%--
Walman Optical CoAnnounced25 Mar 202125 Mar 2021Announced33.37%--
Data delayed at least 15 minutes, as of Dec 02 2021 14:50 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Sonova Holding AG3.01bn644.66m21.66bn14.92k33.108.5725.457.2010.5910.5949.4540.880.56042.837.57216,163.5012.2210.3315.7713.1074.0770.9321.8016.561.3028.530.31132.58-10.804.6631.9510.411.448.79
Koninklijke Philips NV18.21bn1.07bn28.49bn77.75k27.33--11.891.561.144.0819.73--------223,232.70--3.98--5.6944.5646.275.946.03--64.86----0.2723.060.927552.532.611.63
Coloplast A/S2.61bn648.80m28.93bn12.73k48.0228.3138.3011.0722.6322.6391.1238.381.322.636.321,526,241.0032.8932.3553.4754.6168.5367.9524.8423.370.7232--0.254387.954.765.7614.968.9524.827.07
Straumann Holding AG1.73bn343.19m30.43bn8.17k88.8623.2167.9917.5522.4322.43113.3185.850.72231.935.15257,484.0014.4213.4617.6016.2575.3075.2919.9618.552.436.600.344634.41-10.6712.29-70.225.2518.467.53
Sartorius Stedim Biotech SA2.64bn520.65m46.24bn8.75k88.8927.7270.0617.525.645.6428.6118.100.8332.148.75348,874.0016.5013.9322.0818.3053.6451.7119.8116.820.728621.770.267220.4232.5916.6552.6024.8424.6115.33
Siemens Healthineers AG18.00bn1.73bn73.32bn66.00k41.424.4726.334.071.571.5716.3514.540.53524.034.34272,681.805.
EssilorLuxottica SA16.97bn1.35bn80.32bn144.51k59.542.3622.834.733.053.0538.3476.810.31473.247.58117,408.902.712.823.093.3659.7260.538.617.471.9426.050.249259.39-17.0316.53-92.11-35.4214.7314.97
Data as of Dec 02 2021. Currency figures normalised to EssilorLuxottica SA's reporting currency: Euro EUR

Institutional shareholders

10.46%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 05 Nov 20217.47m1.69%
Capital Research & Management Co. (World Investors)as of 30 Sep 20216.74m1.52%
Norges Bank Investment Managementas of 31 Dec 20206.62m1.50%
BlackRock Fund Advisorsas of 04 Nov 20214.62m1.05%
Capital Research & Management Co. (Global Investors)as of 30 Sep 20214.45m1.01%
Massachusetts Financial Services Co.as of 30 Sep 20213.81m0.86%
Amundi Asset Management SA (Investment Management)as of 31 Dec 20203.56m0.81%
TIAA-CREF Investment Management LLCas of 30 Sep 20213.38m0.76%
BlackRock Advisors (UK) Ltd.as of 04 Nov 20213.00m0.68%
Comgest SAas of 31 Jul 20212.60m0.59%
More ▼
Data from 31 Dec 2020 - 23 Nov 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.